Quest Diagnostics
DGX
#1046
Rank
โ‚น2.040 T
Marketcap
โ‚น18,343
Share price
-0.17%
Change (1 day)
22.80%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2025 (TTM): โ‚น747.04

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is โ‚น797.95. In 2024 the company made an earnings per share (EPS) of โ‚น718.52 an increase over its 2023 EPS that were of โ‚น700.97.

EPS history for Quest Diagnostics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น747.043.97%
2024โ‚น718.522.5%
2023โ‚น700.97-5.83%
2022โ‚น744.38-49.21%
2021โ‚น1,46649.72%
2020โ‚น978.9666.67%
2019โ‚น587.3818%
2018โ‚น497.79-4.26%
2017โ‚น519.9623.19%
2016โ‚น422.06-7.11%
2015โ‚น454.3928.46%
2014โ‚น353.72-31.61%
2013โ‚น517.1960.46%
2012โ‚น322.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
LabCorp
LH
โ‚น946.64 18.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-โ‚น65.74-108.24%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น81.27-110.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น181.67-77.23%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-โ‚น19.39-102.43%๐Ÿ‡บ๐Ÿ‡ธ USA